EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark OMJJARA was filed as Word mark on 06/03/2022 at the European Union Intellectual Property Office.
It was registered as a trademark on 10/15/2022.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018712489 |
| Application date | June 3, 2022 |
| Publication date | July 8, 2022 |
| Entry date | October 15, 2022 |
| Expiration date | June 3, 2032 |
Trademark owner
Corporation Service Company 251 Little Falls Drive
19808 Wilmington
US
19808 Wilmington
US
Trademark representatives
Avenida Fotógrafo Francisco Cano 91A
03540 Alicante
ES
goods and services
5
Pharmaceutical preparations and drugs for the treatment of cancer, namely, Myelofibrosis (MF); pharmaceutical preparations and drugs for the treatment of cancer and tumors, treatment of blood diseases or disorders, bone and bone marrow diseases, and cancers associated with blood diseases and/or disorders; Biological and chemical preparations for the treatment of cancer; Pharmaceutical products, preparations, and compounds for the prevention and treatment of cancer and tumors, treatment of blood diseases or disorders, bone and bone marrow diseases, and cancers associated with blood diseases and/or disorders; Pharmaceutical preparations and substance for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical reagents; Medical diagnostic reagents, assays, and test kits for testing of body fluids; cells, protein molecules, and molecular compounds in the nature of drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for medical purposes; DNA damage response assets, namely, pharmaceutical preparations for the treatment of conditions associated with DNA damage, namely cancer, for medical use
42
Pharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of blood diseases, bone and bone marrow diseases, and cancers; scientific research and development; scientific laboratory services; medical laboratory services; conducting clinical trials for others; conducting clinical trial for others regarding pharmaceutical preparations and drugs in the field of blood diseases, bone and bone marrow diseases, and cancers; DNA screening and analysis services for scientific research purposes
44
Medical services; medical testing services; DNA screening and analysis services for medical purposes
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| July 14, 2023 | Transfer / Change of address, Published | ||
| March 24, 2023 | Transfer / Change of address, Published | ||
| February 2, 2023 | Transfer / Change of address, Published | ||
| October 20, 2022 | Transfer / Change of address, Published | ||
| October 17, 2022 | Change Representative, Published | ||
| June 14, 2022 | Transfer / Change of address, Registered |
ID: 11018712489